Elevai Labs(ELAB)
Search documents
Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments
Newsfilter· 2024-04-29 13:45
Five international distribution agreements signed to dateCumulative contracted minimum purchase requirements of $4.9M in the first five yearsUp to five additional international distribution agreements in discussion NEWPORT BEACH, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- ELEVAI Labs Inc. (NASDAQ:ELAB) ("Elevai" or the "Company"), a medical aesthetic company specializing in physician-dispensed skincare, announces significant strides in global distribution and highlights an overview of current agreements. El ...
ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months
Newsfilter· 2024-04-22 12:00
Taiwan is ELEVAI's third Asian contract for exosomes distribution after adding the Philippines in August of 2023 and Vietnam in May 2023 Asia-Pacific represents a combined $13 Billion prestige skincare and luxury haircare market4,5Immediate access to 40 specialty hair treatment clinics and four (4) high-end medical aesthetic clinics NEWPORT BEACH, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- ELEVAI LABS, INC. (NASDAQ:ELAB) ("Elevai" or the "Company"), a medical aesthetic company specializing in physician-disp ...
Elevai Labs(ELAB) - 2023 Q4 - Annual Report
2024-03-29 10:19
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-41875 ELEVAI LABS INC. (Exact name of registrant as specified in its charter) Delaware 85-1399981 (State or other jurisdictio ...
Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
Newsfilter· 2024-03-18 12:30
NEWPORT BEACH, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- ELEVAI LABS, INC., (NASDAQ:ELAB) a medical aesthetic company specializing in physician-dispensed skin care, is proud to announce the launch of its online E-commerce portal. The new E-commerce portal serves as a business-to-business (B2B) extension of the Company's existing B2B relationship with physician dispensed providers currently offering ELEVAI products in the $19.7 billion global industry1. Through the Company's online platform, retail customer ...
Why Is Elevai Labs (ELAB) Stock Up 57% Today?
InvestorPlace· 2024-02-01 13:00
Elevai Labs (NASDAQ:ELAB) stock is rocketing higher on Thursday as the skincare development company’s shares experience heavy trading this morning.That has more than 9.4 million shares of ELAB stock changing hands of this writing. To put that in perspective, the daily average trading volume for Elevai Labs’ shares is closer to 1.2 million units.Investors will note that this extreme stock movement comes without any recent news concerning Elevai Labs. The company has put out any new preleases or filings that ...
Elevai Labs(ELAB) - 2023 Q3 - Quarterly Report
2023-12-10 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Quarterly Period Ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-41875 ELEVAI LABS INC. (Exact name of registrant as specified in its charter) Delaware 85-1399981 (State of incorporation) (I.R.S. Employer Identification No ...